The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Histological and serological features of acute liver injury after SARS-CoV-2 vaccination
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Several drugs and vaccines, including COVID-19 vaccines, have been identified as triggers for the onset of AIH.
“It is notable that several drugs and vaccines - including COVID-19 vaccines more recently – have been identified as triggers for the onset of AIH.”
From Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report (2023) · cites this paper as [8]
Overall, 75% tested positive for ANA, while polyreactive IgG with reactivity against BSA/HIP1R was detected in almost half of patients.
“Overall, 75% tested positive for ANA, while polyreactive IgG with reactivity against BSA/HIP1R (a new biomarker for AIH with a reportedly higher specificity than conventional autoantibodies) was detected in almost half of patients.”
From Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report (2023) · cites this paper as [8]
Relapse of liver injury after a new dose of vaccine occurred in only 25% of cases, which challenges the causal relationship or reflects adaptation to the vaccine.
“In contrast, relapse of liver injury after a new dose of vaccine occurred in only 25% of cases, which challenges the causal relationship or reflects adaptation to the vaccine.”
From Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report (2023) · cites this paper as [8]
The temporal relationship between vaccination and the appearance of the liver injury, and the fact that hepatitis was diagnosed after the 2nd vaccine dose in the majority of cases, suggested causality.
“The temporal relationship between vaccination and the appearance of the liver injury, and the fact that hepatitis was diagnosed after the 2nd vaccine dose in the majority of cases8 suggested causality.”
From Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report (2023) · cites this paper as [8]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
EASL Clinical Practice Guidelines: Drug-induced liver injury
Andrade, R. J., Aithal, G. P., Björnsson, E. S., Kaplowitz, N., Kullak-Ublick, G. A., Larrey, D., & Karlsen, T. H. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.02.014 · Cited by 1,276
Self-citationGargano, J. W., Wallace, M., Hadler, S. C., Langley, G., Su, J. R., Oster, M. E., Broder, K. R., Gee, J., Weintraub, E., Shimabukuro, T., et al. (2021) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7027e2 · Cited by 587
Vergani, D., Alvarez, F., Bianchi, F. B., Cançado, E. L. R., Mackay, I. R., Manns, M. P., Nishioka, M., & Penner, E. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.08.002 · Cited by 446
Self-citation
Flagged first, then by citations
Research works printed but not linked: 37
- Tregoning, 2021, Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape, Nat Rev Immunol, 21, 626, 10.1038/s41577-021-00592-1 · DOI
- 2021, Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine - United States, December 14-23, 2020, MMWR Morb Mortal Wkly Rep, 70, 46, 10.15585/mmwr.mm7002e1 · DOI
- Sharifian-Dorche, 2021, Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis post COVID-19 vaccination; a systematic review, J Neurol Sci, 428, 10.1016/j.jns.2021.117607 · DOI
- Teijaro, 2021, COVID-19 vaccines: modes of immune activation and future challenges, Nat Rev Immunol, 21, 195, 10.1038/s41577-021-00526-x · DOI
- Li, 2022, Autoimmune conditions following mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccination: a descriptive cohort study among 1.1 million vaccinated people in Hong Kong, J Autoimmun, 130, 10.1016/j.jaut.2022.102830 · DOI
- Bril, 2021, Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) Vaccine: causality or casualty?, J Hepatol, 75, 222, 10.1016/j.jhep.2021.04.003 · DOI · Paper page
- Tun, 2021, Immune-mediated hepatitis with the Moderna vaccine, no longer a coincidence but confirmed, J Hepatol, 76, 747, 10.1016/j.jhep.2021.09.031 · DOI
- Ghielmetti, 2021, Acute autoimmune-like hepatitis with atypical anti-mitochondrial antibody after mRNA COVID-19 vaccination: a novel clinical entity?, J Autoimmun, 10.1016/j.jaut.2021.102706 · DOI
- McShane, 2021, The mRNA COVID-19 vaccine - a rare trigger of autoimmune hepatitis?, J Hepatol, 75, 1252, 10.1016/j.jhep.2021.06.044 · DOI
- Londoño, 2021, Another case of autoimmune hepatitis after SARS-CoV-2 vaccination. Still casualty?, J Hepatol [Internet], 75, 1248, 10.1016/j.jhep.2021.06.004 · DOI
- Rela, 2021, Auto-immune hepatitis following COVID vaccination, J Autoimmun, 123, 10.1016/j.jaut.2021.102688 · DOI
- Vuille-Lessard É, 2021, Autoimmune hepatitis triggered by SARS-CoV-2 vaccination, J Autoimmun, 123, 10.1016/j.jaut.2021.102710 · DOI
- Camacho-Domínguez, 2022, COVID-19 vaccine and autoimmunity. A new case of autoimmune hepatitis and review of the literature, J Transl Autoimmun, 5
- Garrido, 2021, Autoimmune hepatitis after COVID-19 vaccine - more than a coincidence, J Autoimmun, 125, 10.1016/j.jaut.2021.102741 · DOI
- Avci, 2021, Autoimmune hepatitis after SARS-CoV-2 vaccine: new-onset or flare-up?, J Autoimmun, 125, 10.1016/j.jaut.2021.102745 · DOI
- Guardiola, 2022, Unexplained liver test elevations after SARS-CoV-2 vaccination, J Hepatol [Internet], 77, 251, 10.1016/j.jhep.2022.02.014 · DOI
- Shroff, 2022, Liver injury following SARS-CoV-2 vaccination: a multicenter case series, J Hepatol, 76, 211, 10.1016/j.jhep.2021.07.024 · DOI
- Chow, 2022, Autoimmune hepatitis-like syndrome following COVID-19 vaccination: a systematic review of the literature, Dig Dis Sci, 67, 4574, 10.1007/s10620-022-07504-w · DOI
- Rüther, 2022, Autoimmune hepatitis and COVID-19: No increased risk for AIH after vaccination but reduced care, J Hepatol, 77, 250, 10.1016/j.jhep.2022.02.013 · DOI
- Mieli-Vergani, 2018, Autoimmune hepatitis, Nat Rev Dis Primers, 4, 10.1038/nrdp.2018.17 · DOI
- Andrade, 2006, Outcome of acute idiosyncratic drug-induced liver injury: long-term follow-up in a hepatotoxicity registry, Hepatology, 44, 1581, 10.1002/hep.21424 · DOI · Paper page
- Fontana, 2010, Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop, Hepatology, 52, 730, 10.1002/hep.23696 · DOI
- Robles-Diaz, 2014, Use of Hy’s law and a new composite algorithm to predict acute liver failure in patients with drug-induced liver injury, Gastroenterology, 147, 109, 10.1053/j.gastro.2014.03.050 · DOI · Paper page
- Ishak, 1995, Histological grading and staging of chronic hepatitis, J Hepatol, 22, 696, 10.1016/0168-8278(95)80226-6 · DOI
- Lohse, 2022, Consensus recommendations for histological criteria of autoimmune hepatitis from the International AIH Pathology Group, Liver Int, 42, 1058, 10.1111/liv.15217 · DOI · Paper page
- Hennes, 2008, Simplified criteria for the diagnosis of autoimmune hepatitis, Hepatology, 48, 169, 10.1002/hep.22322 · DOI · Paper page
- Taubert, 2022, Quantification of polyreactive immunoglobulin G facilitates the diagnosis of autoimmune hepatitis, Hepatology, 75, 13, 10.1002/hep.32134 · DOI · Paper page
- Efe, 2022, Liver injury after SARS-CoV-2 vaccination: features of immune-mediated hepatitis, role of corticosteroid therapy and outcome, Hepatology [Internet], 10.1002/hep.32572 · DOI · Paper page
- Pinazo-Bandera, 2022, Acute hepatitis with autoimmune features after COVID-19 vaccine: coincidence or vaccine-induced phenomenon?, Gastroenterol Rep (Oxf), 10
- Torrente, 2022, Probable autoimmune hepatitis reactivated after COVID-19 vaccination, Gastroenterol Hepatol, 45, 115, 10.1016/j.gastrohep.2021.10.002 · DOI
- Castiella, 2014, Drug-induced autoimmune liver disease: a diagnostic dilemma of an increasingly reported disease, World J Hepatol, 6, 160, 10.4254/wjh.v6.i4.160 · DOI · Paper page
- Lucena, 2011, Recurrent drug-induced liver injury (DILI) with different drugs in the Spanish Registry: the dilemma of the relationship to autoimmune hepatitis, J Hepatol, 55, 820, 10.1016/j.jhep.2010.12.041 · DOI · Paper page
- Mieli-Vergani, 2022, Reassessement of the histological features of autoimmune hepatitis, Liver Int, 42, 954, 10.1111/liv.15219 · DOI
- Petráš, 2021, Can vaccination trigger autoimmune disorders? A meta-analysis, Vaccines, 9, 821, 10.3390/vaccines9080821 · DOI
- Wagner, 2019, Impfen bei Immundefizienz: anwendungshinweise zu den von der Ständigen Impfkommission empfohlenen Impfungen. (IV) Impfen bei Autoimmunkrankheiten, bei anderen chronisch-entzündlichen Erkrankungen und unter immunmodulatorischer Therapie, Bundesgesundheitsbl, 62, 494, 10.1007/s00103-019-02905-1 · DOI
- Chen, 2022, New-onset autoimmune phenomena post-COVID-19 vaccination, Immunology, 165, 386, 10.1111/imm.13443 · DOI
- Boettler, 2022, SARS-CoV-2 vaccination can elicit a CD8 T-cell dominant hepatitis, J Hepatol [Internet], 77, 653, 10.1016/j.jhep.2022.03.040 · DOI
Cited by
Sorted by citations
Andrade, R. J., Aithal, G. P., de Boer, Y. S., Liberal, R., Gerbes, A., Regev, A., Terziroli Beretta-Piccoli, B., Schramm, C., Kleiner, D. E., De Martin, E., et al. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.04.033 · Cited by 166
Self-citation
Metadata
- Authors
- Codoni, G., Kirchner, T., Engel, B., Villamil, A. M., Efe, C., Stättermayer, A. F., Weltzsch, J. P., Sebode, M., Bernsmeier, C., Lleo, A., Gevers, T. J., Kupčinskas, L., Castiella, A., Pinazo, J., De Martin, E., Bobis, I., Sandahl, T. D., Pedica, F., Invernizzi, F., Del Poggio, P., Bruns, T., Kolev, M., Semmo, N., Bessone, F., Giguet, B., Poggi, G., Ueno, M., Jang, H., Elpek, G. Ö., Soylu, N. K., Cerny, A., Wedemeyer, H., Vergani, D., Mieli-Vergani, G., Lucena, M. I., Andrade, R. J., Zen, Y., Taubert, R., & Terziroli Beretta-Piccoli, B.
- ORCID
- Villamil, Alejandra Maria
- Stättermayer, Albert Friedrich
- Sebode, Marcial
- Gevers, Tom JG.
- Castiella, Agustin
- Sandahl, Thomas Damgaard
- Bruns, Tony
- Kolev, Mirjam
- Bessone, Fernando
- Giguet, Baptiste
- Ueno, Masayuki
- Jang, Helena
- Elpek, Gülsüm Özlem
- Soylu, Neşe Karadağ
- Wedemeyer, Heiner
- Lucena, M. Isabel
- Andrade, Raul J.
- Terziroli Beretta-Piccoli, Benedetta
- Venue
- JHEP Reports
- Publisher
- Elsevier BV
- Published
- 2023-01
- Volume
- 5
- Issue
- 1
- Pages
- 100605
- ISSN
- 2589-5559
- PMC
- PMC9691430
- Cited by
- 37
- References
- 3
- Language
- en
- Licence
- Funders
- Medizinischen Hochschule Hannover
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review